1. Home
  2. RCKT vs NNOX Comparison

RCKT vs NNOX Comparison

Compare RCKT & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • NNOX
  • Stock Information
  • Founded
  • RCKT 1999
  • NNOX 2011
  • Country
  • RCKT United States
  • NNOX Israel
  • Employees
  • RCKT N/A
  • NNOX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • NNOX Medical Electronics
  • Sector
  • RCKT Health Care
  • NNOX Health Care
  • Exchange
  • RCKT Nasdaq
  • NNOX Nasdaq
  • Market Cap
  • RCKT 326.4M
  • NNOX 330.6M
  • IPO Year
  • RCKT N/A
  • NNOX 2020
  • Fundamental
  • Price
  • RCKT $2.70
  • NNOX $4.99
  • Analyst Decision
  • RCKT Buy
  • NNOX Strong Buy
  • Analyst Count
  • RCKT 13
  • NNOX 2
  • Target Price
  • RCKT $18.50
  • NNOX $9.50
  • AVG Volume (30 Days)
  • RCKT 8.4M
  • NNOX 1.0M
  • Earning Date
  • RCKT 08-04-2025
  • NNOX 08-19-2025
  • Dividend Yield
  • RCKT N/A
  • NNOX N/A
  • EPS Growth
  • RCKT N/A
  • NNOX N/A
  • EPS
  • RCKT N/A
  • NNOX N/A
  • Revenue
  • RCKT N/A
  • NNOX $11,545,000.00
  • Revenue This Year
  • RCKT N/A
  • NNOX $71.55
  • Revenue Next Year
  • RCKT N/A
  • NNOX $162.32
  • P/E Ratio
  • RCKT N/A
  • NNOX N/A
  • Revenue Growth
  • RCKT N/A
  • NNOX 15.32
  • 52 Week Low
  • RCKT $2.19
  • NNOX $3.75
  • 52 Week High
  • RCKT $26.98
  • NNOX $11.00
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 32.09
  • NNOX 43.18
  • Support Level
  • RCKT $2.66
  • NNOX $4.97
  • Resistance Level
  • RCKT $3.33
  • NNOX $5.35
  • Average True Range (ATR)
  • RCKT 0.28
  • NNOX 0.24
  • MACD
  • RCKT 0.09
  • NNOX -0.04
  • Stochastic Oscillator
  • RCKT 26.59
  • NNOX 7.59

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.

Share on Social Networks: